Oakland, Calif.-based Alameda Health System will assume governance of St. Rose Hospital in Hayward, Calif., amid financial pressures.
Category: Static
United, Duke Health reach contract agreement
Durham, N.C.-based Duke University Health System and UnitedHealthcare have reached a multi-year agreement after months of negotiations to keep 172,000 Duke Health patients in-network, effective Nov. 1.
United, Duke Health reach contract agreement
Durham, N.C.-based Duke University Health System and UnitedHealthcare have reached a multi-year agreement after months of negotiations to keep 172,000 Duke Health patients in-network, effective Nov. 1.
Providence ending some therapy services in Washington, cutting 55 jobs
Providence Swedish in the South Puget Sound region of Washington state will close a majority of its outpatient physical, occupational, and speech therapy programs, according to a news release shared with Becker’s.
Providence ending some therapy services in Washington, cutting 55 jobs
Providence Swedish in the South Puget Sound region of Washington state will close a majority of its outpatient physical, occupational, and speech therapy programs, according to a news release shared with Becker’s.
50% of US drug shortages last at least 2 years: ASHP
A survey by the American Society of Health-System Pharmacists found that 50% of active drug shortages in the U.S. persist for two or more years, the Pharmacy Times reported Nov. 1.
50% of US drug shortages last at least 2 years: ASHP
A survey by the American Society of Health-System Pharmacists found that 50% of active drug shortages in the U.S. persist for two or more years, the Pharmacy Times reported Nov. 1.
State flags Connecticut hospital for service cuts: 9 notes
Connecticut’s Office of Health Strategy has raised concerns with Vernon, Conn.-based Rockville General Hospital’s service cuts that “may be in violation” of state law, according to an Oct. 17 letter.
Prime Healthcare Texas hospital taps CEO
Josiah De La Garza has been named CEO of Dallas Regional Medical Center in Mesquite, Texas.
Semaglutide shows improvement in liver disease treatment in late stage trial
A Novo Nordisk Phase 3 trial found that 37% of adults with metabolic dysfunction-associated steatohepatitis who received once-weekly semaglutide 2.4 milligrams showed improvement in liver fibrosis without worsening steatohepatitis, a disease that cause…
